After canceling a routine meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to review the composition of the 2025-2026 influenza vaccine, the US Food and Drug ...
The US Food and Drug Administration (FDA) has canceled an upcoming meeting of external experts to discuss next year’s influenza vaccine composition. The move follows the indefinite postponement of a ...